Related Experiment Videos
The Dornier-Lithotripter U30. First clinical experience
Archivos Espanoles De Urologia
|May 1, 1996
Summary
Extracorporeal shock wave lithotripsy (ESWL) using the Dornier Lithotripter U-30 effectively treats urinary calculi. This technology offers safe, efficient stone disintegration and a high stone-free rate for patients.
Area of Science:
- Urology
- Nephrology
- Medical Devices
Background:
- Extracorporeal shock wave lithotripsy (ESWL) is a key treatment for urinary calculi.
- Recent ESWL advancements have prioritized economic factors over efficacy or side effect reduction.
- The Dornier Lithotripter U-30 prototype was implemented in clinical practice.
Purpose of the Study:
- To evaluate the efficacy and safety of the Dornier Lithotripter U-30 for urinary stone ablation.
- To assess the device's performance in a clinical setting.
Main Methods:
- Prospective study involving 1092 urinary calculi treated over 16 months.
- Utilized the Dornier Lithotripter U-30 for extracorporeal shock wave lithotripsy.
- Follow-up assessments were conducted at 3 months post-treatment.
Main Results:
- Complete stone disintegration was achieved in 84% of cases.
- After a 3-month follow-up, 85.5% of patients were rendered stone-free.
- The Dornier Lithotripter U-30 demonstrated efficient stone fragmentation.
Conclusions:
- The Dornier Lithotripter U-30 is user-friendly with a minimal learning curve.
- The device is suitable for safe and effective treatment of all urinary calculi.
- Particular efficacy was noted for in situ treatment of ureteral stones.